Introduction
Diagnosis
Biopsy Results
Management
Antibodies
100

Name the 4 of the 6 types of idiopathic inflammatory myopathies

Dermatomyositis, polymyositis, immune-mediated necrotizing myopathy, inclusion body myositis, overlap CTDs, and antisynthetase syndrome

100

What is the best imaging technique to identify muscle inflammation.

MRI

100

What do the skin biopsies show in patients with DM

Interface dermatitis similar to SLE patients

100

True or False: All IIMs are treated up front with glucocorticoids

False: IBM is unresponsive to anti-inflammatory and immunosuppressive treatment, though all other forms are and would be started on steroids. 

100

ANA is present in 60 or 80% of DM/PM myositis patients. 

Up to 60%

200

Name 2 clinical manifestations that all IIMs have in common

progressive muscle weakness and histopathologic findings of inflammatory infiltrates

They differ in specific biopsy findings, serologic abnormalities, prognosis, treatment, and weakness distribution

200

Name all 5 muscle-derived enzymes that can be abnormal in IIMs

CK, LDH, aldolase, AST, and ALT

200

Perivascular inflammation with predominately B-cells with smaller number of CD4-positive T-cells accumulated around blood vessels. Tend to see perifascicular atrophy and vasculitis. 

Dermatomyositis

200

Along with steroids, what treatment can hasten recovery and in what two clinical scenarios is it used?

IVIG and used in severe disease and dysphagia

200

Name the two antibodies that are associated with IMNM

anti-SRP and HMGCR

300

True or False: Normal muscle enzymes rule out myositis

False, there are amyopathic subtypes. In DM this is referred to as having CADM or clinically amyopathic DM

300

True or False: A muscle biopsy is required to diagnose IIMs

False, if presentation is classic particularly in DM and IMNM; biopsy is not required. Though lack of cutaneous manifestations would require a biopsy to confirm. 

300

Endomysial inflammatory infiltrate with predominately CD8 positive T cells

Polymyositis

300

How long should initial dose prednisone be continued prior to taper.

Until CK normalizes and weakness starts to improve, usually around 4 weeks.

300

Name 3 antibodies that if present can suggest overlap syndrome

SSA, SM, RNP, scleroderma specific (PM-Scl & Ku)

400

Most common IIM in patients over 50 years old

Inclusion body myositis

400

Name the characteristic EMG finding that can support a diagnosis of IIM

Presence of fibrillation potentials. Can also be seen in infectious, toxic, and metabolic myopathies. SN 85 SP 33

400

This complex is not normally found in normal muscle but can be isolated from myositis muscle biopsies and is thought to play a role in pathogenesis.

Class I Major Histocompatibility Complex

400

For pts with DM and skin findings, what two treatments can be considered that are skin specific treatments that will not benefit muscle involvement. 

Photoprotection and hydroxychloroquine

400

Name the antibody that is associated with acute onset of DM, traditional shawl or V-sign, and may respond well to therapy.

anti-Mi-2, the antibody may also correlate with disease severity and normalize with disease remission. Low risk of malignancy.

500

Name a few diseases that should be included in your differential when assessing for muscle weakness

Thyroid myopathy, muscular dystrophy (especially adult onset LGMD), metabolic myopathies, drug-induced, infection, sarcoid myopathy, amyloid, ect
500

What instructions are important to include when asking for a muscle biopsy to ensure a good sample. Name at least 3. 

Biopsy location - Newest area of weakness or determined by imaging

Do not use the side that underwent EMG

Do not use electrocautery to cut or place in formalin

Sample should be at least 2cm

The muscle should be kept moist in saline gauze and not submerged

Muscle should be taken to pathology within 30 minutes for best results

500

List pathologic features of IBM on muscle biopsy

Endomysial inflammation due to CD8+ T cells invading nonnecrotic fibers that contain rimmed vacuoles as well as mitochondrial abnormalities including ragged red fibers

500

At what time would you consider tapering off glucocorticoid-sparing agent and which of the 5 subtypes tend to fail treatment discontinuation.

Consider tapering treatment after 1-2 years of steroid free remission. IMNM tend to flare and generally cannot stop treatment. 
500

In TIF-1gamma PM/DM which clinical feature if present further strengthens suspicion for malignancy. 

Not thinking of malignancy specific symptoms like weight loss and pain. 

Ovoid palatal patch; Other TIF features can include palmar hyperkeratotic papules, psoriasis-like lesions, and hypopigmented and telangiectasia patches

M
e
n
u